Geniculate artery embolization in knee OA

  • Research type

    Research Study

  • Full title

    Geniculate artEry embolisatioN in patiEnts with oSteoarthrItiS of the knee\n(GENESIS)

  • IRAS ID

    237676

  • Contact name

    Mark Little

  • Contact email

    mark.little@royalberkshire.nhs.uk

  • Sponsor organisation

    University of Reading

  • Duration of Study in the UK

    4 years, 0 months, 1 days

  • Research summary

    Osteoarthritis (OA) of the knee is an extremely common and debilitating condition with no known cure. Treatment includes pain relief, physiotherapy, steroid injections, weight-loss programs, and joint replacement surgery. Moderate arthritis resistant to nonsurgical options, not yet severe enough to warrant surgery, presents a specific management challenge and justifies research into the area. Studies have shown that OA is mediated by increased vascularity and recent work has shown the benefit of embolising abnormal vessels within the knee to alleviate symptoms of OA. The current study will investigate the clinical success and safety of arterial embolisation in knee OA. Patients with knee OA will complete pain scores and quality of life questionnaires before and after blocking the abnormal vessels in their knees using tiny particles under x-ray guidance (embolization). Patients will also undergo MRI of the affected knee before the procedure and afterwards to assess structural change. The results of this feasibility study will be used to design a larger cohort study.

  • REC name

    London - Bromley Research Ethics Committee

  • REC reference

    18/LO/0335

  • Date of REC Opinion

    19 Apr 2018

  • REC opinion

    Further Information Favourable Opinion